🔴 Solid Biosciences is trading 6.34% down today; no company-specific catalyst identified

Solid Biosciences is trading 6.34% down at $9.60, with no new company-specific catalyst identified for September 8, 2026.

• The latest announcement concerns investor conferences scheduled for September 9 and 10, not a clinical, earnings, regulatory, or financing event directly explaining the decline.
• The broader market is weaker, but S&P 500 and Nasdaq declines are modest; the specific reason for the move remains unclear.